Accidental ingestion of Ecstasy in a toddler

Yi-Jung Chang1, Ming-Wei Lai, Man-Shan Kong

  • 1Division of Pediatric Gastroenterology, Department of Pediatrics, Chang Gung Children's Hospital, Kwei-Shan, Taoyuan, Taiwan.

Insights

Accidental ingestion of 3,4-methylenedioxymethamphetamine (MDMA), or Ecstasy, in toddlers can cause severe neurological and cardiovascular issues. Prompt supportive care is crucial for recovery, as demonstrated in a case of a 20-month-old child.

Area of Science:

  • Pediatric Toxicology
  • Emergency Medicine
  • Pharmacology

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy, is a recreational drug with increasing incidence of abuse.
  • Accidental ingestion in toddlers poses significant risks due to their vulnerability to its potent neurological and cardiovascular effects.

Observation:

  • A 20-month-old male toddler presented with fever, seizures, tachycardia, hypertension, and hyperthermia after accidental Ecstasy ingestion.
  • Initial assessment revealed a high urine amphetamine level (2111 ng/mL).

Findings:

  • The toddler received supportive care, including rapid cooling and hydration.
  • The patient's condition stabilized within 48 hours, with normalization of urine amphetamine levels by day 3.
  • Full recovery was observed at outpatient follow-up, with the child returning to baseline behavior, activity, and appetite.

Implications:

  • This case highlights the critical need to include accidental Ecstasy ingestion in the differential diagnosis for febrile seizures in toddlers.
  • Increased awareness and prompt medical intervention are essential to manage pediatric MDMA toxicity effectively.
  • Healthcare providers should be vigilant regarding the rising incidence of recreational drug abuse and its potential impact on child health.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...